Women's Health Archives - Endocrinology Advisor

Severe Vasomotor Symptoms at Menopause Associated With CVD Risk

August 13, 2020

Among women with menopausal vasomotor symptoms, severity rather than frequency of hot flushes and night sweats is associated with an increased risk for CVD.

Obesity

Medication Use Linked to Weight Gain in Postmenopausal Women

August 11, 2020

For postmenopausal women, antidepressants, beta-blockers, and insulin are associated with weight gain over three years.

Pediatric Endocrinology

No Improvements Seen in Meeting AAP Vitamin D Intake Guidelines

August 4, 2020

Since 2009, there has been no improvement in meeting the American Academy of Pediatrics guidelines for vitamin D intake.

General Endocrinology

Higher Rates of Pain, Bleeding Found With Essure Birth Control Device

July 31, 2020

The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared with tubal ligation.

Obesity

Maternal Obesity May Be Related to Risk for ADHD in Children

July 28, 2020

Mothers with a body mass index (BMI) of 25 kg/m² and greater are more likely to see behavioral problems and psychiatric symptoms in their children.

Practice Management

Employers Can Refuse to Provide Birth Control Coverage, Rules US Supreme Court

July 14, 2020

More than 70,000 US women could be left without cost-free birth control after the Supreme Court upheld a Trump administration policy change that permits some employers to refuse to provide contraceptive coverage on religious or moral grounds.

Androgen and Reproductive Disorders

Contraceptives Beneficial for Premature Ovarian Insufficiency

July 13, 2020

For women with premature ovarian insufficiency, continuous use of combined oral contraceptives is associated with increased BMD, similar to that seen with high-dose hormone therapy.

Androgen and Reproductive Disorders

Sustained Clinical Benefits Observed With Linzagolix in Uterine Fibroid Trials

By

Brian Park, PharmD

July 10, 2020

Positive topline data were announced from two phase 3 studies evaluating the efficacy and safety of linzagolix (Yselty®; ObsEva) for the treatment of heavy menstrual bleeding due to uterine fibroids.